Novartis Venture Fund's book
23 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Binx | — | ▮ | ▮ | ▮ | ▮ |
| Artios | Drug Discovery | ▮ | ▮ | ▮ | ▮ |
| Mediar Therapeutics | — | ▮ | ▮ | ▮ | ▮ |
+ 20 more companies · all 23, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Novartis Venture Fund portfolio at a glance
23 portfolio companies are on record for Novartis Venture Fund, including Binx, Artios and Mediar Therapeutics.
14 of the 23 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 23 recorded positions
- ·Watchlist + alerts for Novartis Venture Fund's activity